IRTC Stock Analysis: Buy, Sell, or Hold?
IRTC - iRhythm Technologies, Inc
$116.80
-1.42 (-1.20%)
▼
5d:
-4.89%
30d:
-8.71%
90d:
-34.17%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 07, 2026
Smart Money Accumulation
IRTC is down 6.5% this week, but smart money is accumulating calls. Top strike: $150 2026-04-17 with 401 OI. Call ratio: 98% View Scanner →
Strength: 8.0/10
Get Alerted When IRTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: IRTC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: IRTC shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$29.30
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$18.19
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: IRTC is currently trading at $116.80, which is considered slightly low relative to its 30-day fair value range of $114.90 to $130.76. The stock's valuation (Forward PE: 139.7) is in line with its historical norms (149.7). Remarkably, the market is currently pricing in an annual earnings decline of 2.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, IRTC is in a strong downtrend. Immediate support is located at $112.98, while resistance sits at $124.40.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $211.43 (+81.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, IRTC is in a strong downtrend. Immediate support is located at $112.98, while resistance sits at $124.40.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $211.43 (+81.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$114.90 -
$130.76
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
83.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 81.0% below Wall St target ($211.43)
Fair Price Analysis
30-Day Fair Range
$114.90 -
$130.76
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$8.64
(7.4%)
Support & Resistance Levels
Support Level
$112.98
Resistance Level
$124.40
Current Trend
Strong Downtrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
139.66
Wall Street Target
$211.43
(+81.0%)
Revenue Growth (YoY)
27.1%
Profit Margin
-6.0%
Valuation Discount vs History
-2.3% cheaper
PE vs Historical
139.7 vs 149.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-2.3%
(market-implied from PE analysis)
1-Year Target
$114.11
(-2%)
2-Year Target
$111.49
(-5%)
3-Year Target
$108.92
(-7%)
3-Yr Target (if PE normalizes)
(PE: 140→150)
$116.75
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 139.7 to 149.7
Stabilization Target:
$125.19
(+7.2%)
PE Expansion Potential:
+7.2%
Share & Embed Analysis
Last updated: April 02, 2026 7:03 PM ET
Data refreshes hourly during market hours. Next update: 8:03 PM
Data refreshes hourly during market hours. Next update: 8:03 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IRTC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Marc Wade Rosenbaum
SELL
816 shares
2026-03-02
Chad Patterson
SELL
4444 shares
2026-03-02
Sumi Shrishrimal
SELL
2830 shares
2026-03-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 56 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 62 BUY |
Advanced IRTC Option Strategies
Professional options setups generated by AI based on today's IRTC price and gamma walls.
